WHO experts recommend adding two candidate vaccines to Ebola trials in DRC
WHO experts recommend expanding clinical trials in the Democratic Republic of the Congo to include two new candidate Ebola vaccines during an ongoing outbreak.
World Health Organization experts have recommended expanding clinical trials in the Democratic Republic of the Congo to include two new candidate Ebola vaccines. The initiative aims to bolster efforts against an ongoing outbreak in the country and potentially save human lives.
Large-scale clinical trials initially launched in late October utilizing Ervebo, an authorized vaccine used against specific Ebola strains. Following recommendations from WHO advisory groups, researchers plan to evaluate the two additional candidates to gather critical data regarding their safety and effectiveness in active outbreak settings.
International health officials expect that incorporating these candidates will enhance response efforts and broaden preventative options across vulnerable regions.
Sources: Digi24.